Treatment | Protein (μg/mg tissue) | GSH (μmole/g tissue) | TBARS (nmole/min/mg tissue) | H2O2 (nmole/min/mg tissue) | DNA injury (%) |
---|---|---|---|---|---|
Control | 2.98 ± 0.13a | 21.05 ± 2.18abc | 2.96 ± 0.28d | 2.49 ± 0.09c | 2.51 ± 0.15d |
DMSO + Olive oil | 2.98 ± 0.09a | 21.35 ± 2.16ab | 3.24 ± 0.36d | 2.60 ± 0.19bc | 2.58 ± 0.15d |
CCl4 | 1.05 ± 0.14†c | 11.38 ± 0.93†e | 6.19 ± 0.65†a | 3.99 ± 0.33†a | 6.22 ± 0.63†a |
CCl4 + silymarin (100 mg/kg) | 2.81 ± 0.10a | 17.87 ± 1.01≠bcd | 4.20 ± 0.27†bc | 2.93 ± 0.20*bc | 2.94 ± 0.21cd |
CCl4 + FXM (200 mg/kg) | 1.87 ± 0.13†b | 14.62 ± 1.56d†e | 4.65 ± 0.47†b | 3.04 ± 0.25≠b | 4.50 ± 0.34†b |
CCl4 + FXM (400 mg/kg) | 2.91 ± 0.11a | 17.73 ± 1.00≠cd | 3.80 ± 0.34≠cd | 2.74 ± 0.35bc | 3.38 ± 0.23†c |
FXM (200 mg/kg) | 2.90 ± 0.13a | 21.74 ± 1.82a | 2.95 ± 0.19d | 2.51 ± 0.21c | 2.55 ± 0.09d |
FXM (400 mg/kg) | 2.89 ± 0.11a | 22.35 ± 1.65a | 3.13 ± 0.33d | 2.49 ± 0.18c | 2.49 ± 0.16d |